Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1973 Mar;132(3):465–474. doi: 10.1042/bj1320465

Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate

Eleonora P Giorgi 1, I M Shirley 1, J K Grant 1, Joan C Stewart 1
PMCID: PMC1177610  PMID: 4125095

Abstract

Hyperplastic and adenocarcinomatous human prostatic tissue was superfused in vitro with radioactively labelled androst-4-ene-3,17-dione, testosterone and 5α-dihydrotestosterone (17β-hydroxy-5α-androstan-3-one), with and without addition of the anti-androgens cyproterone and cyproterone acetate. Cyproterone competitively inhibited the entry of the androgens into the majority of the tissues, whereas cyproterone acetate increased this entry. These findings indicated that transport of androstenedione, testosterone and 5α-dihydrotestosterone into prostatic tissue is performed by a specific mechanism, possibly involving a carrier situated in the cell membrane. The extent of metabolism of the three androgens was also modified: formation of 5α-dihydrotestosterone from testosterone, and of the latter from androstenedione, was decreased by cyproterone and increased by the acetate. Acetate was more effective than cyproterone in decreasing the `uptake' of the perfused androgens by the tissue; at the same time, it increased the androgen clearance from the tissue. As cyproterone acetate is the more potent of the two anti-androgens, the possibility that these findings in vitro are related to the different anti-androgenic potency exhibited by the two compounds in vivo is discussed. `Uptake' of the two anti-androgens and the response to their action on androgen dynamics were similar in adenocarcinomatous and hyperplastic glands.

Full text

PDF
465

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belham J. E., Neal G. E., Williams D. C. Testosterone metabolism in the rat ventral prostate. Biochim Biophys Acta. 1969 Jul 29;187(1):159–162. doi: 10.1016/0005-2760(69)90146-5. [DOI] [PubMed] [Google Scholar]
  2. Breuer H., Hoffman W. Wirkungsmechanismus eines Antiandrogens auf die Androgen-Biosynthese. Naturwissenschaften. 1967 Dec;54(23):616–617. doi: 10.1007/BF00591427. [DOI] [PubMed] [Google Scholar]
  3. Denef C., Vandeputte M., De Moor P. Paradoxical effects of the androgen antagonist cyproterone acetate on steroid metabolism in the rat. Endocrinology. 1968 Nov;83(5):945–955. doi: 10.1210/endo-83-5-945. [DOI] [PubMed] [Google Scholar]
  4. Fang S., Anderson K. M., Liao S. Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem. 1969 Dec 25;244(24):6584–6595. [PubMed] [Google Scholar]
  5. Fang S., Liao S. Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Mol Pharmacol. 1969 Jul;5(4):428–431. [PubMed] [Google Scholar]
  6. Geller J., Vazakas G., Fruchtman B., Newman H., Nakao K., Loh A. The effect of cyproterone acetate on advanced carcinoma of the prostate. Surg Gynecol Obstet. 1968 Oct;127(4):748–758. [PubMed] [Google Scholar]
  7. Giorgi E. P., Grant J. K., Stewart J. C., Reid J. Androgen dynamics in vitro in the canine prostate gland. J Endocrinol. 1972 Nov;55(2):421–439. doi: 10.1677/joe.0.0550421. [DOI] [PubMed] [Google Scholar]
  8. Giorgi E. P., Stewart J. C., Grant J. K., Scott R. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland. Biochem J. 1971 Jun;123(1):41–55. doi: 10.1042/bj1230041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Giorgi E. P., Stewart J. C., Grant J. K., Shirley I. M. Androgen dynamics in vitro in the human prostate gland. Effect of oestradiol-17 . Biochem J. 1972 Jan;126(1):107–121. doi: 10.1042/bj1260107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gurpide E., Welch M. Dynamics of uptake of estrogens and androgens by human endometrium. Application of a double isotope perfusion technique. J Biol Chem. 1969 Oct 10;244(19):5159–5169. [PubMed] [Google Scholar]
  11. Hoffmann W., Breuer H. Wirkung von 1,2lpha-Methylen-6-chlor-delta 4,6-pregnadien-17 alpha-ol-3,20-dion (Cyproteron) auf die Biogenese von C19-Steroiden in Rattentestes. Acta Endocrinol (Copenh) 1968 Apr;57(4):623–638. [PubMed] [Google Scholar]
  12. Hubbell W. L., Metcalfe J. C., Metcalfe S. M., McConnell H. M. The interaction of small molecules with spin-labelled erythrocyte membranes. Biochim Biophys Acta. 1970 Dec 1;219(2):415–427. doi: 10.1016/0005-2736(70)90219-1. [DOI] [PubMed] [Google Scholar]
  13. Neumann F., Berswordt-Wallrabe R V. O., Elger W., Steinbeck H., Hahn J. D., Kramer M. Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horm Res. 1970;26:337–410. doi: 10.1016/b978-0-12-571126-5.50013-3. [DOI] [PubMed] [Google Scholar]
  14. Stern J. M., Eisenfeld A. J. Androgen accumulation andbinding to macromolecules in seminal vesicles: inhibition cyproterone. Science. 1969 Oct 10;166(3902):233–235. doi: 10.1126/science.166.3902.233. [DOI] [PubMed] [Google Scholar]
  15. Vermeulen A., Stoïca T., Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab. 1971 Nov;33(5):759–767. doi: 10.1210/jcem-33-5-759. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES